Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.10.19
关于向控股子公司提供委托贷款的通告
2011.10.19
第二届董事会第九次聚会决议通告
2011.09.30
中国建银投资证券有限责任公司关于公司内部控制规则落真相形自查表及整改妄想的核查意...
2011.09.30
关于内部控制规则落真相形自查报告和整改妄想
2011.09.30
第二届董事会第八次聚会决议通告
2011.09.15
第二届董事会第七次聚会决议通告
2011.09.15
第二届监事会第七次聚会决议通告
2011.09.15
关于对全资子公司举行增资的通告
2011.09.10
关于子公司完成股权变换工商备案的通告
2011.08.27
关于2011年半年度报告更正的通告
第一页
上一页
135
136
137
138
139
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】